Filing Details

Accession Number:
0001209191-13-037009
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-07-17 16:25:24
Reporting Period:
2013-07-17
Filing Date:
2013-07-17
Accepted Time:
2013-07-17 16:25:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1333248 Cadence Pharmaceuticals Inc CADX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1265784 R William Larue C/O Cadence Pharmaceuticals, Inc.
12481 High Bluff Drive, Suite 200
San Diego CA 92130
Svp, Cfo, Treas, Asst Sec No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-07-17 9,000 $3.20 14,000 No 4 M Direct
Common Stock Disposition 2013-07-17 9,000 $7.26 5,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock stock option (right to buy) Disposition 2013-07-17 9,000 $0.00 9,000 $3.20
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
158,250 2016-06-11 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 11,000 Indirect By the LaRue Family Trust
Footnotes
  1. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2013.
  2. This transaction was executed in multiple trades at prices ranging from a low of $7.20 to a high of $7.40. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. Mr. LaRue is a trustee of this trust.
  4. 25% of the 176,250 shares of common stock originally subject to the option vested on 6/12/2007, and 1/48th of the remaining number of shares of common stock subject to the option vested on the first day of each full month thereafter.
  5. Not applicable to this transaction.